Johnny Mahlangu, University of the Witwatersrand (IMAGE)

University of the Witwatersrand

Johnny Mahlangu, University of the Witwatersrand

Caption

Professor Johnny Mahlangu is Head of the School of Pathology at the University of the Witwatersrand, Johannesburg, South Africa. He is the lead author of a paper entitled 'Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors', published in the New England Journal of Medicine on Aug. 30, 2018.

Credit

Wits University

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.